Stratifying according to cancer types proposed that LAPTM4B polymorphism significantly increased the risk of breast cancer, gastrointestinal cancer, gynaecological cancer, liver cancer, lung cancer, and lymphoma (data not shown). This evidence concerns the gene LAPTM4B and liver cancer.